Cite

HARVARD Citation

    Kanazawa, I. et al. (2017). Long-term efficacy and safety of vildagliptin add-on therapy in type 2 diabetes mellitus with insulin treatment. Diabetes research and clinical practice. pp. 9-17. [Online]. 
  
Back to record